Table 3.
Experimental Model |
Ciguatoxins Exposure Protocol | Molecular Target | effects | Reference |
---|---|---|---|---|
SH-SY5Y | 25 pM–100 nM P-CTX-3C short-(4–24 h) and long-term exposure (10 days) | cytotoxic effect, alterations of the mitochondrial metabolism, cell morphology, and [Ca2+]i |
[91] | |
primary cortical neurons | 5 nM CTX3C 6-24- 72 h |
gene expression alteration mediated by voltage-gated sodium channel | [90] | |
C57BL/6 mice |
shallow intraplantar (i.pl.) injection of P-CTX-1 (1–10 nM) | Nav 1.8 and TTXs Nav subtypes are effectors of ciguatoxin-induced cold allodynia | spontaneous pain | [93] |
transgenic mice and rat | 0.01–31 nM P-CTX-1 (>95% purity) isolated from moray eel (Gymnothorax javanicus) liver | NaV1.9 | release of calcitonin-gene related peptide (CGRP) from nerve terminals |
[85] |
C57BL/6 mice |
(0.26 ng/g body weight) intraperitoneally on day 0 followed by second exposure on day 3 P-CTX-1 (isolated and purified from moray eels) | irreversible motor deficit in 4-month pre-exposed mice following peripheral nerve injury astrogliosis and excitotoxic neuronal cell death via the activation of caspase 3 in motor cortex |
[94] |